ACI Clinical provides advisory services to solve complex issues in clinical research. We specialize in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees. By leveraging our in-house experts and biostatistical staff with our global network of over 550 medical experts, ACI Clinical is able to provide our clients with high-value solutions that enhance trial integrity and prepare client data for publication, submission, and approval. Our clients receive the latest scientific and regulatory thinking due to our executive team’s constant involvement in private-public thought leadership efforts focused on establishing best practices. In addition, ACI's in-house team has more committee experience per person than anywhere else in the industry, and our proprietary adjudication technology, AIMS™, has been recognized as the best in the market. Since 2001, ACI has managed projects for hundreds of different pharmaceutical, biopharma, device, biotech and non-profit association clients in virtually every therapeutic area around the world. Our commitment to performance excellence has helped us to support 30 product approvals and numerous publications, with a near 90 percent rate of repeat business.